EXHIBIT 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
PROMIS NEUROSCIENCES INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
| Security |
| Fee |
| Amount |
| Proposed |
| Maximum |
| Fee Rate |
| Amount of | |||||||||||||||
Equity | Common Shares, no par value, underlying Units | 457(c) | 1,383,755 | $ | 5.66(3) | $ | 7,832,053. | (0.00011020) | $ | 863.09 | |||||||||||||||||||
Equity | Common Shares, no par value, issuable upon exercise of Investor Warrants | 457(g) | 345,939(2) | $ | 7.50(4) | $ | 2,594,542 | (0.00011020) | $ | 285.92 | |||||||||||||||||||
Total Offering Amounts | $ | 10,426,595 | $ | 1,149.01 | |||||||||||||||||||||||||
Total Fee Offsets | $ | 0 | |||||||||||||||||||||||||||
Net Fee Due | $ | 1,149.01 |
(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the Registration Statement also covers an indeterminate number of additional Common Shares that may be offered and issued to prevent dilution resulting from share dividends, share splits, reverse share splits, combinations of shares, spin-offs, recapitalizations, mergers or similar capital adjustments.
(2) The number of common shares registered represents Common Shares of the Registrant issuable upon exercise of Investor Warrants.
(3) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act of 1933, as amended, based on the average high and low prices reported for the registrant’s Common Shares as reported on The Nasdaq Capital Market on October 28, 2022.
(4) Calculated pursuant to Rule 457(g) under the Securities Act, based on the exercise price of the warrants ($7.50).